| scholarly article | Q13442814 |
| P50 | author | Kenneth C. Anderson | Q28421846 |
| Katia Todoerti | Q39052018 | ||
| Aldo M Roccaro | Q40001639 | ||
| Antonino Neri | Q56850455 | ||
| Marco Rossi | Q57067930 | ||
| Teresa Calimeri | Q58032684 | ||
| Stefano Molica | Q59660152 | ||
| Fortunato Morabito | Q90396313 | ||
| Pierfrancesco Tassone | Q100766165 | ||
| P2093 | author name string | Nikhil C Munshi | |
| Abdel Kareem Azab | |||
| Constantine S Mitsiades | |||
| Simona Blotta | |||
| Nicola Amodio | |||
| Umberto Foresta | |||
| Jana Jakubikova | |||
| Piersandro Tagliaferri | |||
| P2860 | cites work | Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer | Q21245930 |
| Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance | Q24644883 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| The Hedgehog and Wnt signalling pathways in cancer | Q28189485 | ||
| Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation | Q28200070 | ||
| Hedgehog signaling in animal development: paradigms and principles | Q28208463 | ||
| Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
| Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2 | Q28291091 | ||
| Tissue repair and stem cell renewal in carcinogenesis | Q28294006 | ||
| Identification of an amplified, highly expressed gene in a human glioma | Q28300727 | ||
| Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance | Q33479917 | ||
| Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics | Q33540741 | ||
| Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. | Q33754614 | ||
| Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. | Q33772264 | ||
| Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications | Q33820610 | ||
| Hedgehog signaling is dispensable for adult hematopoietic stem cell function | Q34039421 | ||
| Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia | Q34157874 | ||
| Pathways and consequences: Hedgehog signaling in human disease. | Q34166365 | ||
| Cancer stem cells: controversies in multiple myeloma | Q34462722 | ||
| Essential role of stromally induced hedgehog signaling in B-cell malignancies | Q34651265 | ||
| Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis | Q34727652 | ||
| Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration | Q35080487 | ||
| Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma | Q35143496 | ||
| Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma | Q35652021 | ||
| Sonic hedgehog signalling in T-cell development and activation | Q36906677 | ||
| Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy | Q36921866 | ||
| Multiple myeloma cancer stem cells | Q37029171 | ||
| Hedgehog signalling: emerging evidence for non-canonical pathways | Q37462651 | ||
| Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. | Q37593483 | ||
| The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma | Q38332196 | ||
| Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis | Q38351001 | ||
| Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist | Q39151730 | ||
| Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. | Q39684126 | ||
| Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. | Q39879636 | ||
| Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma | Q39975250 | ||
| Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. | Q42282551 | ||
| Sonic hedgehog is produced by follicular dendritic cells and protects germinal center B cells from apoptosis. | Q45232009 | ||
| Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells | Q46107910 | ||
| Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target | Q46202182 | ||
| Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation | Q46388996 | ||
| Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling | Q46707481 | ||
| A molecular fingerprint for medulloblastoma. | Q47616912 | ||
| The Hedgehog receptor Patched controls lymphoid lineage commitment | Q50899169 | ||
| Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. | Q53338317 | ||
| Targeting the Hedgehog pathway in cancer | Q79397666 | ||
| Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression | Q79954750 | ||
| Cell signaling. A ciliary signaling switch | Q80642248 | ||
| Sonic hedgehog regulates early human thymocyte differentiation by counteracting the IL-7-induced development of CD34+ precursor cells | Q80833064 | ||
| Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells | Q81352006 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| P304 | page(s) | 5002-5013 | |
| P577 | publication date | 2012-07-20 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma | |
| P478 | volume | 120 |
| Q34293000 | A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance |
| Q52646455 | A highlight on Sonic hedgehog pathway. |
| Q51735874 | A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. |
| Q41660964 | Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia |
| Q46027484 | Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. |
| Q26785497 | Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? |
| Q38215035 | Canonical and non-canonical Hedgehog signalling and the control of metabolism |
| Q107098692 | Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 |
| Q37031293 | DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. |
| Q28543228 | Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche |
| Q58615786 | Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway |
| Q89701153 | GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway |
| Q98283428 | Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma |
| Q37427953 | Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma |
| Q58800972 | Hedgehog Signaling Pathway and Autophagy in Cancer |
| Q99591085 | Hedgehog Signaling and Truncated GLI1 in Cancer |
| Q59792326 | Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells |
| Q39991268 | Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment |
| Q38359705 | Hedgehog signaling in cancer stem cells: a focus on hematological cancers. |
| Q38707438 | Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter |
| Q26764740 | Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment |
| Q26852845 | Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis |
| Q36717999 | Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1 |
| Q38459820 | Identification of the key genes connected with plasma cells of multiple myeloma using expression profiles |
| Q40856384 | Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma |
| Q64119119 | L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma and |
| Q34692166 | Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway |
| Q41770950 | Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma |
| Q47804377 | MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. |
| Q38211866 | Molecularly targeted therapies in multiple myeloma |
| Q36355946 | Natural paniceins from mediterranean sponge inhibit the multidrug resistance activity of Patched and increase chemotherapy efficiency on melanoma cells |
| Q38104413 | New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies |
| Q39062578 | Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma |
| Q38127609 | Nonclassical hedgehog-GLI signaling and its clinical implications |
| Q38778519 | Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis |
| Q61135330 | Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects |
| Q58084993 | Regularization and grouping -omics data by GCA method: A transcriptomic case |
| Q38753307 | Signaling Pathways and Emerging Therapies in Multiple Myeloma |
| Q38736251 | Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells |
| Q47218042 | Strategies to target the Hedgehog signaling pathway for cancer therapy. |
| Q37686006 | Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways |
| Q93104726 | Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment |
| Q38193610 | Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies |
| Q38428941 | Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase? |
| Q38970585 | Targeting the Bone Marrow Microenvironment. |
| Q58780352 | Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency |
| Q90731753 | The Hedgehog signal transducer Smoothened and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia |
| Q64245542 | The Importance of the Hedgehog Signaling Pathway in Tumorigenesis of Spinal and Cranial Chordoma |
| Q38287226 | The molecular mechanisms underlying the therapeutic resistance of cancer stem cells |
| Q53202273 | The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration. |
| Q27687567 | The tumor microenvironment shapes hallmarks of mature B-cell malignancies |
| Q38160739 | Unraveling the therapeutic potential of the Hedgehog pathway in cancer |
| Q90266281 | Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer |
| Q41894298 | miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells |
| Q36525161 | miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 |
Search more.